Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1982 Apr;72(4):389–391. doi: 10.2105/ajph.72.4.389

Aspirin and myocardial infarction in young women.

L Rosenberg, D Slone, S Shapiro, D W Kaufman, O S Miettinen, P D Stolley
PMCID: PMC1649911  PMID: 7065319

Abstract

To assess whether aspirin reduces the risk of a first myocardial infarction (MI) in young women, we evaluated data from a case-control study among women less than 50 years of age without a prior MI: 48 of 551 cases of MI and 67 of 896 hospital controls had taken aspirin regularly for at least 12 weeks immediately before admission. The relative risk estimate was 0.8 upon allowance for confounding factors but it was not statistically significant (95 per cent confidence interval, 0.5-1.4). These data alone do not provide evidence of protection by aspirin against a first infarction in young women.

Full text

PDF
389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hammond E. C., Garfinkel L. Aspirin and coronary heart disease: findings of a prospective study. Br Med J. 1975 May 3;2(5965):269–271. doi: 10.1136/bmj.2.5965.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hennekens C. H., Karlson L. K., Rosner B. A case-control study of regular aspirin use and coronary deaths. Circulation. 1978 Jul;58(1):35–38. doi: 10.1161/01.cir.58.1.35. [DOI] [PubMed] [Google Scholar]
  3. Miettinen O. S. Stratification by a multivariate confounder score. Am J Epidemiol. 1976 Dec;104(6):609–620. doi: 10.1093/oxfordjournals.aje.a112339. [DOI] [PubMed] [Google Scholar]
  4. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. doi: 10.1093/oxfordjournals.aje.a112220. [DOI] [PubMed] [Google Scholar]
  5. Mitchell J. R. Secondary prevention of myocardial infarction--the present state of the ART. Br Med J. 1980 May 3;280(6223):1128–1130. doi: 10.1136/bmj.280.6223.1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Moncada S., Vane J. R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979 May 17;300(20):1142–1147. doi: 10.1056/NEJM197905173002006. [DOI] [PubMed] [Google Scholar]
  7. O'Brien J. R., Tulevski V., Etherington M. Two in-vivo studies comparing high and low aspirin dosage. Lancet. 1971 Feb 20;1(7695):399–400. doi: 10.1016/s0140-6736(71)92237-9. [DOI] [PubMed] [Google Scholar]
  8. O'Grady J., Moncada S. Aspirin: A paradoxical effect on bleeding-time. Lancet. 1978 Oct 7;2(8093):780–780. doi: 10.1016/s0140-6736(78)92661-2. [DOI] [PubMed] [Google Scholar]
  9. Shapiro S., Slone D., Rosenberg L., Kaufman D. W., Stolley P. D., Miettinen O. S. Oral-contraceptive use in relation to myocardial infarction. Lancet. 1979 Apr 7;1(8119):743–747. doi: 10.1016/s0140-6736(79)91205-4. [DOI] [PubMed] [Google Scholar]
  10. Walker S. H., Duncan D. B. Estimation of the probability of an event as a function of several independent variables. Biometrika. 1967 Jun;54(1):167–179. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES